Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
Substantial and rapid reductions in body fat leave more excess skin
Hydration Tip: Keep a water bottle and keep sipping frequently throughout the day
Retatrutide 20 mg (PEN PEPTIDE) Next-generation triple agonist 20 mg Pre-Mixed Stabilized Pen PEN PEPTIDE Retatrutide 20 mg from PEN PEPTIDE stabilized pen with triple GLP-1/GIP/glucagon agonist
US$ 24.60
US$ 29.14
US$ 21.43
US$ 25.51
US$ 26.78
